Realtime updates for Hubei Biocause [000627.SZ]

Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. It also engages in the pharmaceutical, chemical, and new energy fuel businesses...

Stats
Current Price	CNY3.32
Today's Volume	22.59M
Average Volume	25.89M
Market Cap	16.40B
EPS	CNY 0.0800
P/E	41.50
ATR14	CNY 0.0090 (0.27%)

Hubei Biocause

Hubei Biocause Pharmaceutical Co., Ltd. primarily provides life and motor insurance products in China. It also engages in the pharmaceutical, chemical, and new energy fuel businesses. In addition, the company is involved in the contract research and production of APIs, intermediates, and formulations, including tablets, granules, capsules, etc.; and provision of chemicals comprising dimethyl ether gas and a-chloropropionyl chloride. It exports its products to approximately 85 countries, including the United States, the European Union, and internationally. The company is based in Jingmen, China.